City

Bethesda (1)

Cairo (1)

Hokkaido (1)

Oakland (1)

Overall Status

Completed (2)

Recruiting (2)

Sign in for free

Phase

n/a (1)

phase 3 (1)

phase 4 (1)

Sponsor

Ain Shams University (1)

Mitsubishi Tanabe Pharma Corporation (1)

National Institute of Allergy and Infectious Diseases (NIAID) (1)

UCSF Benioff Children's Hospital Oakland (1)

Collaborator

National Hepatology & Tropical Medicine Research Institute (1)

University of California, San Francisco (1)

Intervention

bepotastine besilate (1)

care coordination (1)

hydrocortisone (1)

ketotifen fumarate (1)

resiliency clinic (1)

tacrolimus (1)

usual care (1)

Study Documents

Intervention Type

drug (2)

behavioral (1)

Funder Type

Other (2)

Industry (1)

NIH (1)

Study Type

Interventional (3)

Observational (1)

atopic

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Atopic, Dermatitis Trial in Cairo (Tacrolimus, Hydrocortisone)

Recruiting

Atopic
Dermatitis

Cairo, Egypt

Dermatology Clinic of National Hepatology and Tropical Medicine

Apr 5, 2022

Normal Blood, Bone Marrow and Buccal Mucosa Protocol

Recruiting

Non-atopic
+4 more

Bethesda, Maryland

National Institutes of Health Clinical Center, 9000 Rockville Pi

Apr 7, 2022

Fibrinogen Abnormality, Telomere Length, Mean Leukocyte, Atopic Trial in Oakland (Care Coordination, Resiliency Clinic, Usual

Completed

Fibrinogen Abnormality
+5 more

Care Coordination
+2 more

Oakland, California

UCSF Benioff Children's Hospital Oakland

Apr 19, 2021

Dermatitis, Atopic Trial in Hokkaido (Bepotastine besilate, ketotifen fumarate)

Completed

Dermatitis
Atopic

Bepotastine besilate
ketotifen fumarate

Hokkaido, Japan

Medical Corporation Kojinkai Asanuma Dermatology Clinic

Sep 28, 2017